RESUMEN
OBJECTIVE: Human ß-defensin 1 (hBD-1) is a antimicrobial peptide that is constantly secreted by oral tissues. Hangeshashinto (HST), a traditional Japanese medicine, has been reported to be effective against stomatitis. This study aimed to clarify the profile of HST by comparing the system of production of interleukin-1α (IL-1α) and hBD-1 in human oral mucosal epithelial cells with dexamethasone (DEX), a steroid used for the treatment of stomatitis. METHODS: Human oral keratinocytes (HOK) were treated with HST, DEX, or HST components (baicalein, baicalin, berberine, and glycyrrhizin) for 24 h, and subsequently cultured for 24 h with or without Pam3CSK4 or lipopolysaccharide (LPS). The cell supernatants, total RNA, and intracellular proteins were collected, and changes in IL-1α and hBD-1 protein production and gene expression were evaluated using ELISA and RT-PCR. The phosphorylation of NF-kB and the cell proliferative ability of HOK were evaluated by western blotting and XTT assay, respectively. RESULTS: DEX (0.01-10 µM) significantly suppressed IL-1α and hBD-1 production induced by either Pam3CSK4 or LPS, and also decreased cell growth. In contrast, HST inhibited Pam3CSK4- and LPS-induced IL-1α production at a concentration range of 12.5-100 µg/mL without affecting the cell proliferative capacity and hBD-1 production of HOK. Baicalein and baicalin, which are flavonoid ingredients of HST, showed anti-IL-1α production. CONCLUSION: HST may be useful as a therapeutic agent for stomatitis and other inflammatory diseases of the oral cavity.
Asunto(s)
Estomatitis , beta-Defensinas , Humanos , beta-Defensinas/genética , Células Cultivadas , Dexametasona/efectos adversos , Interleucina-1alfa/genética , Interleucina-1alfa/efectos adversos , Interleucina-1alfa/metabolismo , Queratinocitos/metabolismo , Lipopolisacáridos/efectos adversos , Lipopolisacáridos/metabolismo , FN-kappa B/metabolismo , FN-kappa B/farmacología , FN-kappa B/uso terapéutico , Estomatitis/inducido químicamente , Estomatitis/tratamiento farmacológico , Estomatitis/metabolismoRESUMEN
Chronic alcohol consumption, which is observed worldwide, can damage pancreatic tissue and promote pancreatitis. Rhubarb is a widely used traditional Chinese herbal medicine for treating pancreatitis in China. However, few pharmacological studies have investigated its epigenetic regulation. In this study, we investigated whether chronic exposure to alcohol can alter inflammatory gene expression and the epigenetic regulation effect of cooked rhubarb in the pancreatic tissue of rats. First, changes in inflammatory cytokine DNA methylation (IL-10, IL-1α, TNF-α, NF-κB and TGF-ß) were detected in pancreatic tissue of Sprague-Dawley rats with varying alcohol exposure times (4, 6, 8, or 12 weeks), and then with varying doses of cooked rhubarb treatment (3, 6, or 12 g/day). DNA methylation levels, related RNA concentrations and protein expression of specific inflammatory cytokines, and histopathological score were analysed in pancreatic tissue of Sprague-Dawley rats. The results showed that chronic alcohol exposure (8 weeks) reduced the level of IL-1α DNA methylation and increased its protein expression in acinar cells (P < 0.05). In the acinar cells, the level of IL-10 DNA methylation increased, resulting in a reduction of protein expression (P < 0.05). Simultaneously, chronic alcohol exposure increased the pathological damage to the pancreas (P < 0.05). Finally, cooked rhubarb treatment (3 g/kg/day) effectively alleviated these changes in pancreatic tissue from chronic alcohol exposure (P < 0.05). These results indicate that chronic exposure to alcohol leads to changes in DNA methylation and protein expression of inflammatory genes, and cooked rhubarb may have a protective effect on the pancreatic tissue of rats.
Asunto(s)
Epigénesis Genética , Etanol/metabolismo , Medicina Tradicional China , Páncreas/patología , Rheum , Animales , China , Metilación de ADN/efectos de los fármacos , Humanos , Interleucina-10/metabolismo , Interleucina-1alfa/metabolismo , Masculino , Páncreas/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Interleukin-1 (IL1) is a proinflammatory cytokine and promotes cancer cell proliferation and invasiveness in a diversity of cancers, such as breast and colon cancer. Here, we focused on the pharmacological effect of Entelon® (ETL) on the tumorigenesis of triple-negative breast cancer (TNBC) cells by IL1-alpha (IL1A). IL1A enhanced the cell growth and invasiveness of TNBC cells. We observed that abnormal IL1A induction is related with the poor prognosis of TNBC patients. IL1A also increased a variety of chemokines such as CCL2 and IL8. Interestingly, IL1A expression was reduced by the ETL treatment. Here, we found that ETL significantly decreased the MEK/ERK signaling pathway in TNBC cells. IL1A expression was reduced by UO126. Lastly, we studied the effect of ETL on the metastatic potential of TNBC cells. Our results showed that ETL significantly reduced the lung metastasis of TNBC cells. Our results showed that IL1A expression was regulated by the MEK/ERK- and PI3K/AKT-dependent pathway. Taken together, ETL inhibited the MEK/ERK and PI3K/AKT signaling pathway and suppressing the lung metastasis of TNBC cells through downregulation of IL1A. Therefore, we propose the possibility of ETL as an effective adjuvant for treating TNBC.
Asunto(s)
Metástasis de la Neoplasia/tratamiento farmacológico , Extractos Vegetales/farmacología , Vitis/metabolismo , Animales , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Transformación Celular Neoplásica/efectos de los fármacos , Quimiocinas/metabolismo , Humanos , Interleucina-1alfa/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Ratones , Fosfatidilinositol 3-Quinasas/metabolismo , Extractos Vegetales/metabolismo , Semillas/metabolismo , Transducción de Señal/efectos de los fármacos , Neoplasias de la Mama Triple Negativas/tratamiento farmacológicoRESUMEN
BACKGROUND: Herbal extracts with fewer adverse effects can be an alternative to these drugs because they can target various molecular pathways of acne pathogenesis. OBJECTIVES: To evaluate the clinical efficacy of herbal extracts (mangosteen, Lithospermum officinale, Tribulus terrestris L., Houttuynia cordata Thunb) for the treatment of mild to moderate acne vulgaris. METHODS: Sixty patients were randomized in a 1:1 ratio to receive blinded treatment with herbal extracts or vehicle for 8 weeks. Inflammatory and non-inflammatory acne lesion counts, Investigator's Global Assessment, patient's satisfaction and safety profiles were assessed. We also performed skin biopsy at baseline and week 8 to confirm immunological changes with immunohistochemistry staining. RESULTS: By the end of the study period, both inflammatory and non-inflammatory acne lesion counts were significantly decreased in herbal extracts group (p< .05). In immunohistochemistry staining, expressions of IL-1α, IL-8, and keratin 16 were significantly decreased in herbal extracts group compared to vehicle group from baseline to week 8. There was no serious adverse events in both groups. CONCLUSIONS: This herbal extracts can be a new therapeutic option for patients with mild to moderate acne vulgaris who are reluctant to use drugs.
Asunto(s)
Acné Vulgar/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Acné Vulgar/patología , Administración Cutánea , Adulto , Método Doble Ciego , Esquema de Medicación , Femenino , Garcinia mangostana/química , Garcinia mangostana/metabolismo , Humanos , Interleucina-1alfa/metabolismo , Lithospermum/química , Lithospermum/metabolismo , Masculino , Satisfacción del Paciente , Extractos Vegetales/química , Índice de Severidad de la Enfermedad , Piel/metabolismo , Piel/patología , Resultado del Tratamiento , Adulto JovenRESUMEN
Benzoyl peroxide (BPO) has been widely used to treat acne vulgaris. Skin flaking, erythema and skin irritation have been observed as side effects of BPO in the treatment of this disorder. In a clinical study, cherry bark-containing jumihaidokuto significantly reduced the erythema induced by BPO application. However, its mechanism of action has not been clarified. In the present study, an application of 10% BPO caused erythema and an increase in interleukin (IL)-1α in the skin of hairless mice, and these changes were significantly suppressed by cherry bark-containing jumihaidokuto at 600 mg/kg. In addition, using a three-dimensional cultured human epidermis model (LabCyte EPI-MODEL), cherry bark-containing jumihaidokuto extract at 250 or 500 µg/mL significantly suppressed IL-1α mRNA expression induced by the application of 0.2 mM BPO. Therefore, cherry bark-containing jumihaidokuto may have suppressed BPO-induced erythema by inhibiting the increase in the IL-1α level in the skin.
Asunto(s)
Peróxido de Benzoílo/efectos adversos , Eritema/inducido químicamente , Eritema/tratamiento farmacológico , Fitoterapia , Extractos Vegetales/uso terapéutico , Acné Vulgar/tratamiento farmacológico , Animales , Peróxido de Benzoílo/uso terapéutico , Células Cultivadas , Quimioterapia Combinada , Epidermis/metabolismo , Eritema/metabolismo , Expresión Génica/efectos de los fármacos , Humanos , Interleucina-1alfa/genética , Interleucina-1alfa/metabolismo , Masculino , Ratones Pelados , Corteza de la Planta/química , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , ARN Mensajero/genética , ARN Mensajero/metabolismoRESUMEN
BACKGROUND: Bacterial vaginosis (BV) increases HIV risk and adverse reproductive outcomes. Standard-of-care (SOC) for BV are antibiotics; however, cure rates are low. Probiotics for vaginal health may be useful in improving cure and recurrence although the regulatory framework governing probiotics and the conduct of randomized clinical trials to evaluate these has not been established in South Africa. We performed an exploratory single-blind trial evaluating a commercial oral-vaginal-combination probiotic as adjunct to SOC for BV treatment. METHODS: Women with symptomatic vaginal discharge were screened for BV and common sexually transmitted infections (STIs). BV+ (Nugent 7-10) but STI- women were randomized to vaginal metronidazole alone (n = 12) or to metronidazole followed by a commercial oral/vaginal probiotic (n = 18). The primary qualitative outcome was to test the regulatory landscape for conducting randomized probiotic trials in South Africa; and acceptability of vaginal application by women. BV cure at 1 month (Nugent≤3) was the primary quantitative endpoint. Secondary quantitative endpoints were BV recurrence, symptoms, vaginal microbiota and genital cytokine changes over 5 months post-treatment. RESULTS: The South African Health Products Regulatory Authority (SAHPRA) reviewed and approved this trial. As probiotics continue to be regulated as health supplements in South Africa, SAHPRA required a notification application for this trial. Acceptability and adherence to the oral and vaginal application of the probiotic were high, although women reported a preference for oral capsules. 44.8% of women cleared BV one-month post-treatment, and no significant differences in BV cure (RR = 0.52, 95% CI = 0.24-1.16), recurrence, vaginal pH, symptoms, microbiota or vaginal IL-1α concentrations were found between SOC and intervention groups in this pilot study with an over-the-counter product. CONCLUSION: Navigation of the SAHPRA registration process for evaluating a commercial probiotic in a randomised trial laid the foundation for planned larger trials of improved probiotic products for vaginal health in South Africa. Although adherence to the vaginally delivered probiotic was high, women preferred oral application and we recommend that improvements in the content and method of application for future probiotics for vaginal health should be considered. TRIAL REGISTRATION: This trial was registered on 17 October 2017 with the South African National Clinical Trial Register ( http://www.sanctr.gov.za/ ; BV-trial1; DOH-27-1117-5579 ).
Asunto(s)
Probióticos/uso terapéutico , Vaginosis Bacteriana/microbiología , Vaginosis Bacteriana/terapia , Administración Intravaginal , Adulto , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Suplementos Dietéticos , Aprobación de Drogas , Femenino , Humanos , Interleucina-1alfa/metabolismo , Cumplimiento de la Medicación , Metronidazol/administración & dosificación , Metronidazol/uso terapéutico , Microbiota , Proyectos Piloto , Recurrencia , Método Simple Ciego , Sudáfrica , Resultado del Tratamiento , Adulto JovenRESUMEN
Excessive intake of phosphate has been known to induce renal tubular damage and interstitial inflammation, leading to acute kidney injury or chronic kidney disease in rodents and humans. However, sensitive and early biomarkers for phosphate-induced kidney damage remain to be identified. Our previous RNA sequencing analysis of renal gene expression identified interleukin-36α (IL-36α) as a gene significantly upregulated by dietary phosphate load in mice. To determine the time course and dose dependency of renal IL-36α expression induced by dietary phosphate load, we placed mice with or without uninephrectomy on a diet containing either 0.35%, 1.0%, 1.5%, or 2.0% inorganic phosphate for 10 days, 4 weeks, or 8 weeks and evaluated renal expression of IL-36α and other markers of tubular damage and inflammation by quantitative RT-PCR, immunoblot analysis, and immunohistochemistry. We found that IL-36α expression was induced in distal convoluted tubules and correlated with phosphate excretion per nephron. The increase in IL-36α expression was simultaneous with but more robust in amplitude than the increase in tubular damage markers such as Osteopontin and neutrophil gelatinase-associated lipocalin, preceding the increase in expression of other inflammatory cytokines, including transforming growth factor-α, interleukin-1ß, and transforming growth factor-ß1. We conclude that IL-36α serves as a marker that reflects the degree of phosphate load excreted per nephron and of associated kidney damage.
Asunto(s)
Interleucina-1alfa/metabolismo , Túbulos Renales/metabolismo , Fosfatos/efectos adversos , Lesión Renal Aguda/inducido químicamente , Lesión Renal Aguda/metabolismo , Animales , Biomarcadores/metabolismo , Citocinas/metabolismo , Suplementos Dietéticos , Expresión Génica/genética , Inflamación/metabolismo , Interleucina-1alfa/análisis , Interleucinas/efectos adversos , Interleucinas/metabolismo , Riñón/patología , Túbulos Renales/fisiopatología , Masculino , Ratones , Ratones Endogámicos C57BL , Fosfatos/metabolismo , Transducción de Señal/genéticaRESUMEN
OBJECTIVE: The moisturizing and irritation effects of sacha inchi oil were evaluated. STUDY DESIGN: The moisturizing effect on the skin was clinically assessed using a regression study design. Sacha inchi oil or olive oil (benchmark) was applied on the left or right lower leg of the subjects for 14 days followed by application discontinuation for 2 days. The TEWL, skin moisture content and dryness appearance were observed. METHODS: The fatty acid composition and characteristics of cold-pressed sacha inchi seed oil were determined. Skin tissues cultured ex vivo were used to assess primary irritation induced by the oil by examining keratin 1 expression and TNF-α and IL-1α release from the oil-applied tissues. RESULTS: The sacha inchi oil contained 42.3% linolenic acid and 39.5% linoleic acid. This oil's saponification, iodine, acid and peroxide values were 168.58 ± 1.55 mg KOH/g, 203.00 ± 0.04 g I2 /100 g, 1.68 ± 0.03 mg KOH/g, and 1.95 ± 0.26 mEq peroxide/kg, respectively. Compared with nontreated skin tissues, induced secretion of TNF-α and IL-1α and disruption of keratin 1 integrity in the stratum corneum layer were not found in the sacha inchi oil-treated tissues. In a clinical study with 13 volunteers, the improvement in moisture content and skin dryness appearance at the sacha inchi oil-applied site was comparable with that observed at the olive oil-applied site. CONCLUSIONS: The sacha inchi oil was mild to the skin and benefited dry skin.
Asunto(s)
Cosmecéuticos/administración & dosificación , Epidermis/efectos de los fármacos , Euphorbiaceae/química , Aceites de Plantas/administración & dosificación , Semillas/química , Adulto , Biopsia , Cosmecéuticos/efectos adversos , Cosmecéuticos/química , Elasticidad/efectos de los fármacos , Epidermis/metabolismo , Epidermis/patología , Femenino , Voluntarios Sanos , Humanos , Interleucina-1alfa/metabolismo , Ácido Linoleico/análisis , Persona de Mediana Edad , Aceites de Plantas/efectos adversos , Aceites de Plantas/química , Pruebas de Irritación de la Piel , Resultado del Tratamiento , Factor de Necrosis Tumoral alfa/metabolismo , Pérdida Insensible de Agua/efectos de los fármacos , Adulto Joven , Ácido alfa-Linolénico/análisisRESUMEN
Several therapeutic nanosystems have been engineered to remedy the shortcomings of cancer monotherapies, including immunotherapy (stimulating the host immune system to eradicate cancer), to improve therapeutic efficacy with minimizing off-target effects and tumor-induced immunosuppression. Light-activated components in nanosystems confer additional phototherapeutic effects as combinatorial modalities; however, systemic and thermal toxicities with unfavorable accumulation and excretion of nanoystem components now hamper their practical applications. Thus, there remains a need for optimal multifunctional nanosystems to enhance targeted, durable, and mild combination therapies for efficient cancer treatment without notable side effects. Methods: A nanosystem constructed with a base core (poly-L-histidine [H]-grafted black phosphorus [BP]) and a shell (erythrocyte membrane [EM]) is developed to offer a mild photoresponsive (near-infrared) activity with erythrocyte mimicry. In-flight electrostatic tailoring to extract uniform BP nanoparticles maintains a hydrodynamic size of <200 nm (enabling enhanced permeability and retention) after EM cloaking and enhances their biocompatibility. Results: Ephrin-A2 receptor-specific peptide (YSA, targeting cancer cells), interleukin-1α silencing small interfering RNA (ILsi, restricting regulatory T cell trafficking), and paclitaxel (X, inducing durable chemotherapeutics) are incorporated within the base core@shell constructs to create BP-H-ILsi-X@EM-YSA architectures, which provide a more intelligent nanosystem for combination cancer therapies. Conclusion: The in-flight tailoring of BP particles provides a promising base core for fabricating <200 nm EM-mimicking multifunctional nanosystems, which could be beneficial for constructing smarter nanoarchitectures to use in combination cancer therapies.
Asunto(s)
Antineoplásicos Fitogénicos/administración & dosificación , Nanopartículas/química , Neoplasias Experimentales/terapia , Paclitaxel/administración & dosificación , Fósforo/química , Tratamiento con ARN de Interferencia/métodos , Animales , Antineoplásicos Fitogénicos/uso terapéutico , Línea Celular Tumoral , Membrana Celular/química , Terapia Combinada/métodos , Eritrocitos/química , Histidina/química , Interleucina-1alfa/genética , Interleucina-1alfa/metabolismo , Ratones , Ratones Endogámicos C57BL , Nanopartículas/efectos adversos , Neoplasias Experimentales/tratamiento farmacológico , Paclitaxel/uso terapéuticoRESUMEN
The present work investigated the antioxidative, anti-inflammatory and pulmonary protective effects of enzymatic- and acid- hydrolysed mycelia polysaccharides (En-MPS and Ac-MPS) from Oudemansiella radicata on LPS-induced acute lung injury (ALI) mice. The results demonstrated that both En-MPS and Ac-MPS showed potential pulmonary protective effects by decreasing serum levels of hs-CRP and C3, increasing pulmonary enzyme values of SOD, GSH-Px, CAT and the level of T-AOC; reducing the activity of MPO; and down-regulating the contents of MDA and LPO. In addition, the levels of TNF-É, IL-1ß, and IL-6 in BALF of mice treated with En-MPS at a dosage of 400 mg/kg/d were significantly lower than those in the ALI mice. The in vitro antioxidant effects also showed that the En-MPS was more effective than Ac-MPS. Furthermore, the physical properties of polysaccharides were also investigated by GC, HPGPC, FT-IR and NMR. These results indicated that both En-MPS and Ac-MPS possessed potent antioxidant and anti-inflammatory activities, which could be used as an ingestible drug in preventing lung injury.
Asunto(s)
Agaricales/química , Antiinflamatorios no Esteroideos/uso terapéutico , Antioxidantes/uso terapéutico , Lesión Pulmonar/tratamiento farmacológico , Micelio/química , Polisacáridos/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/química , Antiinflamatorios no Esteroideos/toxicidad , Antioxidantes/química , Antioxidantes/toxicidad , Celulasa/química , Glucuronidasa/química , Hidrólisis , Interleucina-1alfa/metabolismo , Interleucina-6/metabolismo , Pulmón/patología , Lesión Pulmonar/patología , Masculino , Ratones , Complejos Multienzimáticos/química , Poligalacturonasa/química , Polisacáridos/química , Polisacáridos/toxicidad , Sustancias Protectoras/química , Sustancias Protectoras/uso terapéutico , Sustancias Protectoras/toxicidad , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Phosphatidylserine (PtdSer) is mainly derived from the bovine brain cortex or soybean lecithin. We investigated macrophage uptake behavior and the anti-inflammatory response induced by liposomes containing bovine brain- (B-PSL) or soybean-derived PtdSer (S-PSL). The size of B-PSL and S-PSL was very similar. There were no significant differences in the uptake of B-PSL and S-PSL by Raw 264.7 macrophage cells. Addition of B-PSL or S-PSL decreased the production of the inflammatory cytokines, IL-1α, IL-6 and TNF-α, in lipopolysaccharide-treated Raw 264.7 cells, but there were no differences between them. These results suggest that S-PSL may be used as an anti-inflammatory agent.
Asunto(s)
Liposomas/metabolismo , Macrófagos/metabolismo , Fosfatidilserinas/metabolismo , Animales , Antiinflamatorios , Bovinos , Corteza Cerebral , Mediadores de Inflamación/metabolismo , Interleucina-1alfa/metabolismo , Interleucina-6/metabolismo , Lecitinas , Liposomas/farmacología , Ratones , Fosfatidilserinas/farmacología , Células RAW 264.7 , Glycine max , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
BACKGROUND: Boswellia serrata gum resin has attracted pharmacological interest as an alternative antinflammatory. PURPOSE: We studied the application of an ethanolic extract of the resin and its main active 3-O-acetyl-11-keto-ß-boswellic acid (AKBA) against inflammatory degeneration of skin extracellular matrix. STUDY DESIGN: We compared the effects of the extract and AKBA on the activity of MMP-2 and MMP-9 (72-kDa and 92-kDa type IV collagenases) in HaCaT keratinocytes exposed to interleukin-1α (IL-1α) as a skin inflammation model. METHODS: MMP activity in cell conditioned medium was assayed by gelatin zymography, while NF-kB and MAP kinase activations were evaluated by Western blotting. RESULTS: IL-1α (10â¯ng/ml) upregulated MMP-9 but not MMP-2 in HaCaT cells. The extract, used at 2.3, 4.6 and 9.3⯵g/ml, had no effect, but in combination with IL-1α showed MMP-9 inhibition at the lowest dose and increased upregulation at the highest one. AKBA alone, at the same concentrations (corresponding to 5, 10, and 20⯵M), did not stimulate MMP-9, but together with IL-1α induced an increased upregulation at the lowest dose that progressively disappeared at higher doses. WB analysis showed that IL-1α induced phosphorylation of NF-κB p65, while AKBA abolished this effect at 20⯵M, but conversely increased it at 5⯵M. Screening of MAP kinase phosphorylation showed a combined activation of IL-1α/AKBA on JNK, while the JNK inhibitor SP600125 abolished MMP-9 upregulation induced by IL-1α/AKBA. CONCLUSION: The enhancing effect of IL-1α/AKBA on MMP-9 at low AKBA concentration seems to involve the activation of JNK-mediated NF-κB pathway. Conversely, the extract inhibits the IL-1α effect at low doses, but not at higher ones, where AKBA and possibly other ß-boswellic acids reach concentrations that potentiate the effect of IL-1α. The extract at low doses could protect the skin against degenerative processes of extracellular matrix, while keto-ß-boswellic acids seem unsuitable for this purpose.
Asunto(s)
Boswellia/química , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Queratinocitos/efectos de los fármacos , Metaloproteinasa 9 de la Matriz/metabolismo , Triterpenos/farmacología , Línea Celular , Activación Enzimática/efectos de los fármacos , Humanos , Interleucina-1alfa/metabolismo , Interleucina-1alfa/farmacología , Queratinocitos/metabolismo , FN-kappa B/metabolismo , Extractos Vegetales/química , Extractos Vegetales/farmacología , Resinas de Plantas/química , Piel/citología , Regulación hacia Arriba/efectos de los fármacosRESUMEN
The association of diabetes and cognitive decline may indicate that high sugar level might be a risk factor for Alzheimer's disease. A collective term 'diabetes associated cognitive decline' (DACD) has been coined for the patients with type 2 diabetes mellitus showing decline in their cognitive function, especially weak episodic memory, cognitive inflexibility and poor psychomotor performance leading towards Alzheimer's disease. However, at present, no specific treatment exists for the prevention and/or treatment of DACD. Genistein, an isoflavone phytoestrogen, reveals neuroprotective effects in many experimental murine models, though its role on DACD with probable mechanistic approach has still been scope for research. The motive behind the present study is to investigate the outcome of genistein treatment against DACD in streptozotocin-induced diabetic mice with Morris water maze paradigm followed by open field trial to rule out the possibility of impairment in locomotor performance. Chronic (30 days) genistein treatment (2.5, 5.0 and 10.0 mg/kg, i.p. once daily) in diabetic mice significantly lowered hyperglycemia, recovered cognitive performance by affecting acetylcholinesterase activity and oxidative stress and ameliorated neuro-inflammatory condition by varying TNF-α, IL-1ß and nitrite levels as impaired in diabetic mice. Thirty days treatment with vitamin C or metformin also improved diabetes-induced memory impairment and significantly dragged these biochemical parameters towards respective controls. Locomotor performance was not influenced by diabetic condition or any associated treatment. It is concluded that genistein supplementation might be a prospective therapeutic approach for the treatment and/or avoidance of diabetic linked learning and memory dysfunction.
Asunto(s)
Acetilcolinesterasa/metabolismo , Antiinflamatorios/farmacología , Antioxidantes/metabolismo , Trastornos del Conocimiento/tratamiento farmacológico , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Tipo 2/complicaciones , Genisteína/farmacología , Hipoglucemiantes/farmacología , Animales , Antiinflamatorios/uso terapéutico , Trastornos del Conocimiento/etiología , Trastornos del Conocimiento/psicología , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Experimental/psicología , Diabetes Mellitus Tipo 2/inducido químicamente , Diabetes Mellitus Tipo 2/psicología , Proteínas Ligadas a GPI/metabolismo , Genisteína/uso terapéutico , Glutatión/metabolismo , Hipoglucemiantes/uso terapéutico , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Interleucina-1alfa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Consolidación de la Memoria/efectos de los fármacos , Ratones , Nitritos/metabolismo , Estreptozocina , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Survival after lung transplantation is hampered by chronic lung allograft dysfunction (CLAD). Persistently elevated BAL-neutrophilia is observed in some patients despite treatment with azithromycin, which may be induced by IL-1α. Our aim is to establish an in vitro model, assess mechanistic pathways and test different therapeutic strategies of IL-1α-induced release of IL-8 by human bronchial epithelial cells. Bronchial epithelial cells (16HBE) were stimulated with IL-1α with or without azithromycin or dexamethasone. IL-8 protein was analyzed in cell supernatant. Different MAP kinases (p38, JNK, ERK1/2 , Iκß) and targets known to be involved in tumor formation (PI3K, Akt) were investigated. Finally, different treatment options were tested for their potential inhibitory effect. IL-1α induced IL-8 in bronchial epithelial cells, which was dose-dependently inhibited by dexamethasone but not by azithromycin. IL-1α induced p38 and Akt phosphorylation, but activation of these MAPK was not inhibited by dexamethasone. JNK, ERK1/2 , Iκß and PI3K were not activated. None of the tested drugs reduced the IL-1α induced IL-8 production. We established an in vitro model wherein steroids inhibit the IL-1α-induced IL-8 production, while azithromycin was ineffective. Despite using this simple in vitro model, we could not identify a new treatment option for azithromycin-resistant airway neutrophilia.
Asunto(s)
Bronquios/metabolismo , Células Epiteliales/metabolismo , Interleucina-1alfa/metabolismo , Interleucina-8/metabolismo , Acetatos/farmacología , Acetilcisteína/farmacología , Aminopiridinas , Antiinfecciosos/farmacología , Antiinflamatorios no Esteroideos/farmacología , Azitromicina/química , Benzamidas , Bronquios/efectos de los fármacos , Línea Celular , Ciclopropanos , Dapsona/farmacología , Dexametasona/química , Relación Dosis-Respuesta a Droga , Fluoroquinolonas/farmacología , Humanos , Sistema de Señalización de MAP Quinasas , Moxifloxacino , Neutrófilos/metabolismo , Fosforilación , Piridonas/farmacología , Quinolinas/farmacología , Sulfuros , Teofilina/farmacología , Resultado del TratamientoRESUMEN
Plant derived arabinogalactan proteins (AGP) were repeatedly confirmed as immunologically as well as dermatologically active compounds. However, little is currently known regarding their potential activity toward skin innate immunity. Here, we extracted and purified AGP from acacia (Acacia senegal) and baobab (Adansonia digitata) seeds to investigate their biological effects on the HaCaT keratinocyte cell line in an in vitro system. While AGP from both sources did not exhibit any cytotoxic effect, AGP from acacia seeds enhanced cell viability. Moreover, real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) analysis showed that AGP extracted from both species induced a substantial overexpression of hBD-2, TLR-5, and IL1-α genes. These data suggest that plant AGP, already known to control plant defensive processes, could also modulate skin innate immune responses. J. Cell. Physiol. 232: 2558-2568, 2017. © 2016 Wiley Periodicals, Inc.
Asunto(s)
Acacia/química , Adansonia/química , Inmunidad Innata/efectos de los fármacos , Factores Inmunológicos/farmacología , Queratinocitos/efectos de los fármacos , Mucoproteínas/farmacología , Semillas/química , Piel/efectos de los fármacos , Línea Celular , Relación Dosis-Respuesta a Droga , Humanos , Factores Inmunológicos/química , Factores Inmunológicos/aislamiento & purificación , Interleucina-1alfa/genética , Interleucina-1alfa/metabolismo , Queratinocitos/inmunología , Queratinocitos/metabolismo , Mucoproteínas/química , Mucoproteínas/aislamiento & purificación , Fitoterapia , Proteínas de Plantas/química , Proteínas de Plantas/aislamiento & purificación , Proteínas de Plantas/farmacología , Plantas Medicinales , Conformación Proteica , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Piel/inmunología , Piel/metabolismo , Factores de Tiempo , Receptor Toll-Like 6/genética , Receptor Toll-Like 6/metabolismo , Regulación hacia Arriba , beta-Defensinas/genética , beta-Defensinas/metabolismoRESUMEN
Cellular senescence is a stable cell cycle arrest that is the causative process of aging. The PI3K/AKT/mTOR pathway is implicated in the control of cellular senescence and inhibitors of this pathway have been successfully used for life span prolongation experiments in mammals. PTEN is the major regulator of the PI3K/AKT/mTOR pathway and loss of PTEN promotes a senescence response termed PICS. Here we report a novel-screening assay, for the identification of compounds that block different types of senescence response. By testing a library of more than 3000 natural and chemical compounds in PTEN deficient cells we have found that an extract from Salvia haenkei (SH), a native plant of Bolivia is a potent inhibitor of PICS. SH also decreases replicative and UV-mediated senescence in human primary fibroblasts and in a model of in vitro reconstructed human epidermis. Mechanistically, SH treatment affects senescence driven by UV by interfering with IL1-α signalling. Pre-clinical and clinical testing of this extract by performing toxicity and irritability evaluation in vitro also demonstrate the safety of SH extract for clinical use as anti-aging skin treatment.
Asunto(s)
Senescencia Celular/efectos de los fármacos , Extractos Vegetales/farmacología , Salvia/química , Animales , Proliferación Celular/efectos de los fármacos , Proliferación Celular/efectos de la radiación , Células Cultivadas , Senescencia Celular/efectos de la radiación , Fibroblastos/efectos de los fármacos , Regulación de la Expresión Génica , Humanos , Peróxido de Hidrógeno/metabolismo , Interleucina-1alfa/genética , Interleucina-1alfa/metabolismo , Ratones , Estrés Oxidativo , Extractos Vegetales/químicaRESUMEN
Ultraviolet B (UVB) radiation is one of the major predisposing risk factors of skin cancer. The anticancer and photoprotective effects of unoxidized rooibos (Aspalathus linearis) and honeybush (Cyclopia) herbal teas, containing high levels of dihydrochalones and xanthones, respectively, have been demonstrated in skin cancer models in vivo. In the current study, the anti-inflammatory effects of methanol and aqueous extracts of these herbal teas were investigated in a UVB/HaCaT keratinocyte model with intracellular interleukin-1α (icIL-1α) accumulation as a biomarker. Extracts of green tea (Camellia sinensis) served as benchmark. Both extracts of green tea and rooibos, as well as the aqueous extract of C. intermedia, enhanced UVB-induced inhibition of cell viability, proliferation and induction of apoptosis, facilitating the removal of icIL-1α. The underlying mechanisms may involve mitochondrial dysfunction exhibiting pro-oxidant responses via polyphenol-iron interactions. The methanol extracts of honeybush, however, protected against UVB-induced reduction of cell growth parameters, presumably via antioxidant mechanisms that prevented the removal of highly inflamed icIL-1α-containing keratinocytes via apoptosis. The dual antioxidant and/or pro-oxidant role of the polyphenolic herbal tea constituents should be considered in developing preventive strategies against UVB-induced skin carcinogenesis. The indirect removal of UVB damaged keratinocytes by herbal tea extracts via apoptosis may find application in the prevention of photo-induced inflammation.
Asunto(s)
Antiinflamatorios/farmacología , Fabaceae/química , Interleucina-1alfa/metabolismo , Queratinocitos/efectos de los fármacos , Queratinocitos/efectos de la radiación , Extractos Vegetales/farmacología , Antiinflamatorios/química , Aspalathus/química , Biomarcadores/metabolismo , Línea Celular , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Cyclopia (Planta)/química , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Modelos Biológicos , Extractos Vegetales/química , Té/química , Tés de Hierbas/análisisRESUMEN
BACKGROUND/PURPOSE: Urocanic acid (UCA) absorbs ultraviolet (UV)B radiation in the epidermis which may interfere with phototherapy. Therefore, the influence of individual levels of UCA on immune reactivity and vitamin D synthesis induced by narrowband UVB radiation was assessed. METHODS: Twenty-eight subjects with irritant contact dermatitis of the hands were irradiated with suberythemal doses of narrowband UVB radiation on their unaffected lower forearms on three consecutive days. Stratum corneum tape strips and epidermal interstitial fluid (ISF) as well as blood samples were analyzed. RESULTS: Narrowband UVB irradiation led to the conversion of trans-UCA into its cis-isomer in the epidermis. The observed increase in 25-hydroxyvitamin D serum concentrations was inversely correlated with the baseline levels of trans-UCA. Furthermore, UVB irradiation induced significant changes in the levels of CXCL10/IP-10, CCL2/MCP-1, CCL4/MIP-1ß, and the IL-1RA/IL-1α ratio. The levels of IL-1α and CXCL9/MIG showed a trend toward increase. The changes in the levels of inflammatory and immunomodulatory mediators did not depend on baseline levels of trans-UCA. CONCLUSION: The results suggest that epidermal levels of trans-UCA affect vitamin D synthesis, but not cutaneous immune reactivity upon repeated exposure to suberythemal doses of narrowband UVB radiation. However, this requires further exploration.
Asunto(s)
Dermatitis por Contacto/metabolismo , Dermatitis por Contacto/radioterapia , Epidermis/metabolismo , Terapia Ultravioleta , Ácido Urocánico/metabolismo , Vitamina D/análogos & derivados , Adolescente , Adulto , Quimiocinas/metabolismo , Dermatitis por Contacto/patología , Epidermis/patología , Femenino , Proteínas Filagrina , Humanos , Proteína Antagonista del Receptor de Interleucina 1/metabolismo , Interleucina-1alfa/metabolismo , Masculino , Persona de Mediana Edad , Rayos Ultravioleta , Vitamina D/metabolismoRESUMEN
Betel quid (BQ) chewing is an etiologic factor of oral submucous fibrosis (OSF) and oral cancer. There are 600 million BQ chewers worldwide. The mechanisms for the toxic and inflammatory responses of BQ are unclear. In this study, both areca nut (AN) extract (ANE) and arecoline stimulated epidermal growth factor (EGF) and interleukin-1α (IL-1α) production of gingival keratinocytes (GKs), whereas only ANE can stimulate a disintegrin and metalloproteinase 17 (ADAM17), prostaglandin E2 (PGE2) and 8-isoprostane production. ANE-induced EGF production was inhibited by catalase. Addition of anti-EGF neutralizing antibody attenuated ANE-induced cyclooxygenase-2 (COX-2), mature ADAM9 expression and PGE2 and 8-isoprostane production. ANE-induced IL-1α production was inhibited by catalase, anti-EGF antibody, PD153035 (EGF receptor antagonist) and U0126 (MEK inhibitor) but not by α-naphthoflavone (cytochrome p450-1A1 inhibitor). ANE-induced ADAM17 production was inhibited by pp2 (Src inhibitor), U0126, α-naphthoflavone and aspirin. AG490 (JAK inhibitor) prevented ANE-stimulated ADAM17, IL-1α, PGE2 production, COX-2 expression, ADAM9 maturation, and the ANE-induced decline in keratin 5 and 14, but showed little effect on cdc2 expression and EGF production. Moreover, ANE-induced 8-isoprostane production by GKs was inhibited by catalase, anti-EGF antibody, AG490, pp2, U0126, α-naphthoflavone, Zinc protoporphyrin (ZnPP) and aspirin. These results indicate that AN components may involve in BQ-induced oral cancer by induction of reactive oxygen species, EGF/EGFR, IL-1α, ADAMs, JAK, Src, MEK/ERK, CYP1A1, and COX signaling pathways, and the aberration of cell cycle and differentiation. Various blockers against ROS, EGF, IL-1α, ADAM, JAK, Src, MEK, CYP1A1, and COX can be used for prevention or treatment of BQ chewing-related diseases.
Asunto(s)
Areca/toxicidad , Encía/efectos de los fármacos , Queratinocitos/efectos de los fármacos , Extractos Vegetales/toxicidad , Transducción de Señal/efectos de los fármacos , Proteína ADAM17/efectos de los fármacos , Proteína ADAM17/metabolismo , Línea Celular , Dinoprost/análogos & derivados , Dinoprost/metabolismo , Dinoprostona/metabolismo , Factor de Crecimiento Epidérmico/efectos de los fármacos , Factor de Crecimiento Epidérmico/metabolismo , Humanos , Interleucina-1alfa/metabolismo , Quinasas Janus/efectos de los fármacos , Quinasas Janus/metabolismo , Especies Reactivas de Oxígeno/metabolismoRESUMEN
Oral epithelial cells produce antimicrobial peptides (AMPs) to prevent microbial infection. Calprotectin (S100A8/S100A9) is one of these AMPs in oral epithelial cells, the expression of which is up-regulated by interleukin-1α (IL-1α). Hangeshashinto (HST) is a traditional Japanese herbal medicine that has anti-inflammatory effects. The purpose of this study was to investigate the effect of HST on the expression of calprotectin through the regulation of IL-1α in oral epithelial cells. Human oral epithelial cells (TR146) were cultured with HST in the presence or absence of anti-IL-1α antibody or IL-1 receptor antagonist, or with six major components of HST (3,4-dihydroxybenzaldehyde, baicalin, ginsenoside Rb1, glycyrrhizin, oleanolic acid and berberine). The expression of S100A8, S100A9, other AMPs and cytokine mRNAs was examined by RT-PCR and quantitative real-time PCR. Calprotectin expression and IL-1α secretion were investigated by ELISA. HST (6 µg/ml) increased the expression of S100A8/S100A9 mRNAs and calprotectin protein, and also up-regulated ß-defensin 2 (DEFB4) and S100A7 expression. The expression of IL-1α mRNA and its protein was slightly but significantly increased by HST. A neutralizing antibody against IL-1α and IL-1 receptor antagonist inhibited HST-up-regulated S100A8/S100A9 mRNA expression. Although 3,4-dihydroxybenzaldehyde, baicalin and ginsenoside Rb1 as HST components increased S100A8/S100A9 expression, oleanolic acid and berberine decreased their expression. These results suggest that HST increases the expression of calprotectin, DEFB4 and S100A7 in oral epithelial cells. In response to HST, up-regulation of calprotectin expression may be partially induced via IL-1α.